业界动态国内医卫资讯

贝美司他联合放化疗延长非小细胞肺癌无进展生存期

Medscape News · 2026-11-10 23:20

摘要

研究人员评估贝美司他联合或不联合安罗替尼,用于不可切除的III期非小细胞肺癌患者放化疗后巩固治疗的疗效。Medscape医学新闻

English
Benmelstobart Extends PFS After Chemoradiotherapy in NSCLC

Researchers evaluate benmelstobart, with or without anlotinib, for use as consolidation therapy after chemoradiotherapy in patients with unresectable stage III non-small cell lung cancer. Medscape Medical News

内容仅供参考,不构成诊疗建议,不能替代执业医师的诊断。

← 返回元界